PT3369732T - Compostos moduladores do recetor de androgénio - Google Patents

Compostos moduladores do recetor de androgénio

Info

Publication number: PT3369732T
Authority: PT; Portugal
Prior art keywords: androgen receptor; modulating compounds; receptor modulating; compounds; androgen
Prior art date: 2009-10-27

Application number

PT181637653T

Other languages

English (en)

Original Assignee

Orion Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-10-27

Filing date

2010-10-27

Publication date

2021-07-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43383475&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3369732(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-10-27 Application filed by Orion Corp filed Critical Orion Corp

2021-07-06 Publication of PT3369732T publication Critical patent/PT3369732T/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Dentistry (AREA)
Plant Pathology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Environmental Sciences (AREA)
Pest Control & Pesticides (AREA)
Agronomy & Crop Science (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

PT181637653T 2009-10-27 2010-10-27 Compostos moduladores do recetor de androgénio PT3369732T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US25515909P	2009-10-27	2009-10-27

Publications (1)

Publication Number	Publication Date
PT3369732T true PT3369732T (pt)	2021-07-06

Family

ID=43383475

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
PT211696158T PT3885340T (pt)	2009-10-27	2010-10-27	Compostos moduladores do recetor de androgénio
PT107819187T PT2493858E (pt)	2009-10-27	2010-10-27	Compostos moduladores do recetor de androgénio
PT181637653T PT3369732T (pt)	2009-10-27	2010-10-27	Compostos moduladores do recetor de androgénio
PT161577168T PT3056485T (pt)	2009-10-27	2010-10-27	Compostos moduladores do recetor de androgénio

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
PT211696158T PT3885340T (pt)	2009-10-27	2010-10-27	Compostos moduladores do recetor de androgénio
PT107819187T PT2493858E (pt)	2009-10-27	2010-10-27	Compostos moduladores do recetor de androgénio

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PT161577168T PT3056485T (pt)	2009-10-27	2010-10-27	Compostos moduladores do recetor de androgénio

Country Status (37)

Country	Link
US (5)	US8975254B2 (pt)
EP (5)	EP3885340B1 (pt)
JP (1)	JP5763083B2 (pt)
KR (2)	KR101654529B1 (pt)
CN (2)	CN102596910B (pt)
AR (1)	AR078793A1 (pt)
AU (1)	AU2010311299C1 (pt)
BR (1)	BR112012008823B8 (pt)
CA (1)	CA2777896C (pt)
CL (1)	CL2012000772A1 (pt)
CO (1)	CO6531494A2 (pt)
CY (2)	CY2020010I2 (pt)
DK (4)	DK3885340T3 (pt)
EA (1)	EA021170B1 (pt)
ES (4)	ES2486263T3 (pt)
FI (1)	FI3885340T3 (pt)
GE (1)	GEP20166472B (pt)
HR (4)	HRP20241681T1 (pt)
HU (4)	HUE055528T2 (pt)
IL (2)	IL218586A (pt)
LT (4)	LT3369732T (pt)
LU (1)	LUC00154I2 (pt)
MX (1)	MX2012004867A (pt)
MY (1)	MY159924A (pt)
NL (1)	NL301041I2 (pt)
NO (1)	NO2020018I1 (pt)
NZ (1)	NZ598747A (pt)
PE (1)	PE20121058A1 (pt)
PH (1)	PH12012500782A1 (pt)
PL (4)	PL3885340T3 (pt)
PT (4)	PT3885340T (pt)
RS (4)	RS57592B1 (pt)
SI (4)	SI2493858T1 (pt)
SM (3)	SMT202100480T1 (pt)
UA (1)	UA109535C2 (pt)
WO (1)	WO2011051540A1 (pt)
ZA (1)	ZA201202655B (pt)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR112013000925A2 (pt) *	2010-07-15	2020-12-01	Bayer Intellectual Property Gmbh	compostos heterocíclicos como pesticidas
KR101958177B1 (ko) *	2011-04-21	2019-03-15	오리온 코포레이션	안드로겐 수용체 조절성 카복스아미드
EP2574607A1 (en) *	2011-09-06	2013-04-03	F. Hoffmann-La Roche AG	PDE10 modulators
MY198666A (en) *	2012-03-15	2023-09-14	Signal Pharm Llc	Treatment of cancer with tor kinase inhibitors
JPWO2013141362A1 (ja) *	2012-03-23	2015-08-03	日本農薬株式会社	チアゾールカルボキサミド誘導体及びその使用方法
HK1203197A1 (en)	2012-06-15	2015-10-23	Taisho Pharmaceutical Co., Ltd.	Branched chain alkyl heteroaromatic ring derivative
US9724351B2 (en)	2012-08-23	2017-08-08	Alios Biopharma, Inc.	Compounds for the treatment of paramoxyvirus viral infections
CN102952095A (zh) *	2012-10-19	2013-03-06	盛世泰科生物医药技术(苏州)有限公司	一种2-羧酸乙酯-5-溴甲基噻唑的合成方法
PH12021550330A1 (en) *	2013-08-21	2022-09-28	Janssen Biopharma Inc	Antiviral compounds
WO2015172196A1 (en) *	2014-05-13	2015-11-19	Monash University	Heterocyclic compounds and use of same
HK1245791A1 (zh)	2015-01-20	2018-08-31	阿尔维纳斯运营股份有限公司	用於雄激素受体的靶向降解的化合物和方法
US12312316B2 (en)	2015-01-20	2025-05-27	Arvinas Operations, Inc.	Compounds and methods for the targeted degradation of androgen receptor
PT3250554T (pt)	2015-01-30	2022-06-02	Orion Corp	Um derivado de carboxamida e os seus diastereómeros na forma cristalina estável
MA41614A (fr) *	2015-02-25	2018-01-02	Alios Biopharma Inc	Composés antiviraux
BR112017021636B1 (pt)	2015-04-09	2023-01-24	Orion Corporation	Processos para a preparação de 2-cloro-4-(1h-pirazol-3-il) benzonitrila (v) e n-((s)-1-(3-(3-cloro-4-cianofenil)-1h-pirazol-1-il)-propan-2-il)-5-(1- hidroxietil)-1h-pirazol-3-carboxamida (1a)
HK1248070A1 (zh) *	2015-05-18	2018-10-12	转化药物开发有限责任公司	作为激酶抑制剂的杂环化合物
EP3388428B1 (en) *	2015-12-07	2021-08-04	Suzhou Sinovent Pharmaceuticals Company	Five-membered heterocyclic amides wnt pathway inhibitor
CN107286094A (zh) *	2016-04-12	2017-10-24	常州爱诺新睿医药技术有限公司	一种bay-1841788与药用辅料的固体分散体及其制备方法
CN109641851B (zh) *	2016-08-26	2022-09-02	拜耳消费者护理股份有限公司	一种雄激素受体拮抗剂药物的晶型及其制备方法和用途
LT3660004T (lt)	2016-10-11	2023-06-12	Arvinas Operations, Inc.	Junginiai ir metodai, skirti tikslinei androgeno receptoriaus degradacijai
FI3592732T3 (fi)	2017-03-07	2025-05-28	Orion Corp	Kiteisen farmaseuttisen tuotteen valmistus
EP3645005A1 (en)	2017-06-28	2020-05-06	Bayer Consumer Care AG	Combination of a pi3k-inhibitor with an androgen receptor antagonist
WO2019028689A1 (zh) *	2017-08-09	2019-02-14	杭州领业医药科技有限公司	Odm-201晶型及其制备方法和药物组合物
CN107602471B (zh) *	2017-09-22	2021-04-27	成都恒汇化成医药科技有限公司	一种达罗鲁胺的晶型制备方法
US20210087175A1 (en) *	2018-02-27	2021-03-25	Sandoz Ag	Crystalline Form II of Darolutamide
WO2020035880A1 (en) *	2018-08-13	2020-02-20	National Centre For Biological Sciences-Tifr	Inhibitors to target hiv-1 nef-cd80/cd86 interactions for therapeutic intervention
JP2022509917A (ja)	2018-11-05	2022-01-25	ファイザー・インク	がんを処置するための組合せ
JP2022523094A (ja)	2019-01-30	2022-04-21	アラゴンファーマシューティカルズ，インコーポレイテッド	転移性去勢感受性前立腺癌の治療のための抗アンドロゲン剤
WO2020173457A1 (zh) *	2019-02-27	2020-09-03	深圳市塔吉瑞生物医药有限公司	取代的吡唑类化合物及包含该化合物的组合物及其用途
TW202440088A (zh)	2019-07-02	2024-10-16	芬蘭商奧利安公司	達洛魯胺之醫藥組成物
CN110590668A (zh) *	2019-07-17	2019-12-20	江苏君若医药有限公司	N-[(1s)-2-[3-(3-氯-4-氰基苯基)-1h-吡唑-1-基]-1-甲基乙基]-5-(1-羟基乙基)- 1h-吡唑-3-甲酰胺的制备方法
CA3148115A1 (en)	2019-08-08	2021-02-11	Laekna Limited	Method of treating cancer
CN111116476A (zh) *	2019-12-27	2020-05-08	武汉九州钰民医药科技有限公司	制备抗肿瘤药物多拉米胺的方法
EP4146642A1 (en)	2020-05-09	2023-03-15	Arvinas Operations, Inc.	Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, and dosage forms comprising the same
KR20230009958A (ko) *	2020-05-11	2023-01-17	오리온 코포레이션	안드로겐 수용체 길항제 및 이의 중간체의 제조 방법
BR112023002295A2 (pt)	2020-08-13	2023-03-14	Pfizer	Terapia de combinação
CN111978534B (zh) *	2020-09-07	2022-05-31	陕西师范大学	一种含苯并咪唑液晶基元的侧链型液晶离聚物及其制备方法
KR20230159510A (ko)	2021-03-24	2023-11-21	화이자 인코포레이티드	Ddr 유전자 돌연변이된 전이성 거세-감수성 전립선암의 치료를 위한 탈라조파립과 항안드로겐의 조합
KR102798817B1 (ko) *	2021-08-04	2025-04-23	주식회사 엘지화학	신규한 화합물 및 이를 포함한 유기 발광 소자
CN113527208A (zh) *	2021-08-31	2021-10-22	江西金丰药业有限公司	一步法制备2-氯-4-（1h-吡唑-3-基）苯甲腈的方法
CN113861115A (zh) *	2021-09-10	2021-12-31	浙江师范大学	一种吡唑酰胺类衍生物及合成方法和应用
EP4706772A3 (en)	2022-02-28	2026-04-29	Química Sintética, S.A.	Crystalline form of darolutamide
JP7805983B2 (ja)	2022-03-22	2026-01-26	アッヴィ・インコーポレイテッド	ブルトン型チロシンキナーゼを分解するためのピリミジン
AU2023248685A1 (en)	2022-04-07	2024-11-14	Astrazeneca Ab	Combination therapy for treating cancer
TWI883565B (zh)	2022-10-02	2025-05-11	美商輝瑞大藥廠	用於治療轉移性去勢抵抗性前列腺癌之他拉唑帕尼及恩雜魯胺之組合
WO2024121163A1 (en)	2022-12-06	2024-06-13	Cancer Research Technology Limited	Combination of 10d1f and an androgen inhibitor for treatment and prevention of cancers
TW202425976A (zh)	2022-12-17	2024-07-01	美商輝瑞大藥廠	用於治療轉移性去勢抵抗性前列腺癌之他拉唑帕尼及恩雜魯胺之組合
TW202521513A (zh)	2023-08-17	2025-06-01	芬蘭商奧利安公司	雄性素受體拮抗劑及其中間物之製備方法
CN117776973A (zh) *	2023-09-20	2024-03-29	山东特珐曼药业有限公司	一种4-甲酰基-3-甲氧基苯甲腈的制备方法
WO2025122895A1 (en)	2023-12-08	2025-06-12	Arvinas Operations, Inc.	Use of androgen receptor degrader for the treatment of spinal and bulbar muscular atrophy
WO2025146444A1 (en)	2024-01-03	2025-07-10	Bayer Aktiengesellschaft	Darolutamide in combination with braf and mek inhibitors for melanoma treatment
WO2025229051A1 (en)	2024-05-03	2025-11-06	F. Hoffmann-La Roche Ag	Use of atr inhibitors in combination with antiandrogen agent
WO2026078615A1 (en)	2024-10-09	2026-04-16	Pfizer Inc.	Combination of talazoparib and enzalutamide in the treatment of metastatic castration-resistant prostate cancer
WO2026078619A1 (en)	2024-10-09	2026-04-16	Pfizer Inc.	Combination of talazoparib and enzalutamide in the treatment of metastatic castration-resistant prostate cancer
CN121226255A (zh) *	2025-09-25	2025-12-30	安徽益普克医药科技发展有限公司	一种达罗他胺衍生物及其制备方法与用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE28864T1 (de)	1982-07-23	1987-08-15	Ici Plc	Amide-derivate.
FR2656609B1 (fr)	1989-12-28	1992-03-27	Synthelabo	Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
US5578550A (en)	1993-10-08	1996-11-26	American Cyanamid Company	Herbicidal oxadiazole carbonamide compounds
FR2741342B1 (fr)	1995-11-22	1998-02-06	Roussel Uclaf	Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
PL346795A1 (en)	1998-09-22	2002-02-25	Yamanouchi Pharma Co Ltd	Cyanophenyl derivatives
JP2005508978A (ja)	2001-11-02	2005-04-07	ファイザー・プロダクツ・インク	Ｐｄｅ９阻害薬によるインスリン抵抗性症候群及び２型糖尿病の治療
WO2003057669A1 (fr)	2001-12-28	2003-07-17	Takeda Chemical Industries, Ltd.	Antagonistes du recepteur androgene
EP1465872A1 (en) *	2001-12-28	2004-10-13	Bayer Pharmaceuticals Corporation	4-sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
WO2003057673A1 (en) *	2001-12-28	2003-07-17	Bayer Pharmaceuticals Corporation	1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
WO2003073999A2 (en) *	2002-03-01	2003-09-12	Pintex Pharmaceuticals, Inc.	Pini-modulating compounds and methods of use thereof
TW200406386A (en) *	2002-06-07	2004-05-01	Novartis Ag	Organic compounds
JP2005539001A (ja) *	2002-08-02	2005-12-22	アージェンタ・ディスカバリー・リミテッド	ヒストンデアセチラーゼインヒビターとしての置換チエニルヒドロキサム酸
DE10322108B4 (de)	2003-05-09	2008-12-11	Bayer Schering Pharma Aktiengesellschaft	Antiandrogene Pyrrolidine mit tumorhemmender Wirksamkeit
WO2004111012A1 (ja)	2003-06-12	2004-12-23	Chugai Seiyaku Kabushiki Kaisha	イミダゾリジン誘導体
CA2539117A1 (en)	2003-09-24	2005-04-07	Methylgene Inc.	Inhibitors of histone deacetylase
KR20070106969A (ko)	2004-09-09	2007-11-06	추가이 세이야쿠 가부시키가이샤	신규 이미다졸리딘 유도체 및 그 용도
JP2008007405A (ja) *	2004-12-07	2008-01-17	Takeda Chem Ind Ltd	カルボキサミド誘導体
EP1710237A1 (en) *	2005-04-08	2006-10-11	Bayer CropScience S.A.	New heterocyclylethylbenzamide derivatives
CA2608436C (en)	2005-05-13	2015-03-24	The Regents Of The University Of California	Diarylhydantoin compounds and their use in the treatment of hyperproliferative disorders
US7709516B2 (en)	2005-06-17	2010-05-04	Endorecherche, Inc.	Helix 12 directed non-steroidal antiandrogens
US20090227571A1 (en) *	2005-07-01	2009-09-10	Ligand Pharmaceuticals Incorporated	Androgen Receptor Modulator Compounds and Methods
GB0518237D0 (en) *	2005-09-07	2005-10-19	Angeletti P Ist Richerche Bio	Therapeutic compounds
EP2298770A1 (en)	2005-11-03	2011-03-23	ChemBridge Corporation	Heterocyclic compounds as TrkA modulators
TW200800997A (en)	2006-03-22	2008-01-01	Astrazeneca Ab	Chemical compounds
WO2008062878A1 (fr) *	2006-11-22	2008-05-29	Nihon Nohyaku Co., Ltd.	Nouveau dérivé de pyrazole, agent de lutte contre des organismes nuisibles et utilisation de l'agent de lutte contre des organismes nuisibles
WO2008124000A2 (en)	2007-04-02	2008-10-16	Ligand Pharmaceuticals Incorporated	Thiazole derivatives as androgen receptor modulator compounds
NZ582349A (en) *	2007-06-29	2012-06-29	Sunesis Pharmaceuticals Inc	Heterocyclic compounds useful as raf kinase inhibitors
AR068813A1 (es)	2007-08-30	2009-12-09	Takeda Pharmaceutical	Derivados de pirazol sustituidos como antagonistas del receptor de androgenos (ar), un agente farmaceutico que los comprende y su uso en el tratamiento del cancer de prostata
EP2220050A2 (en)	2007-10-26	2010-08-25	The Regents Of The University Of California	Diarylhydantoin compounds as androgen receptor modulators
PE20091653A1 (es)	2008-03-26	2009-11-14	Takeda Pharmaceutical	Derivados sustituidos de pirazol y su uso
US20110306597A1 (en)	2008-06-18	2011-12-15	James Michael Crawforth	Nicotinamide Derivatives

2010
- 2010-10-26 AR ARP100103942A patent/AR078793A1/es active IP Right Grant
- 2010-10-27 ES ES10781918.7T patent/ES2486263T3/es active Active
- 2010-10-27 WO PCT/FI2010/000065 patent/WO2011051540A1/en not_active Ceased
- 2010-10-27 SI SI201030739T patent/SI2493858T1/sl unknown
- 2010-10-27 KR KR1020127013214A patent/KR101654529B1/ko active Active
- 2010-10-27 FI FIEP21169615.8T patent/FI3885340T3/fi active
- 2010-10-27 PL PL21169615.8T patent/PL3885340T3/pl unknown
- 2010-10-27 GE GEAP201012722A patent/GEP20166472B/en unknown
- 2010-10-27 PL PL18163765T patent/PL3369732T3/pl unknown
- 2010-10-27 LT LTEP18163765.3T patent/LT3369732T/lt unknown
- 2010-10-27 JP JP2012535889A patent/JP5763083B2/ja active Active
- 2010-10-27 SI SI201031718T patent/SI3056485T1/en unknown
- 2010-10-27 KR KR1020167023703A patent/KR101670299B1/ko active Active
- 2010-10-27 RS RS20180913A patent/RS57592B1/sr unknown
- 2010-10-27 EP EP21169615.8A patent/EP3885340B1/en active Active
- 2010-10-27 PT PT211696158T patent/PT3885340T/pt unknown
- 2010-10-27 DK DK21169615.8T patent/DK3885340T3/da active
- 2010-10-27 PL PL10781918T patent/PL2493858T3/pl unknown
- 2010-10-27 SM SM20210480T patent/SMT202100480T1/it unknown
- 2010-10-27 RS RS20210903A patent/RS62123B1/sr unknown
- 2010-10-27 DK DK10781918.7T patent/DK2493858T3/da active
- 2010-10-27 EA EA201270597A patent/EA021170B1/ru active Protection Beyond IP Right Term
- 2010-10-27 EP EP10781918.7A patent/EP2493858B1/en active Active
- 2010-10-27 HU HUE18163765A patent/HUE055528T2/hu unknown
- 2010-10-27 AU AU2010311299A patent/AU2010311299C1/en active Active
- 2010-10-27 PE PE2012000424A patent/PE20121058A1/es active IP Right Grant
- 2010-10-27 EP EP18163765.3A patent/EP3369732B1/en active Active
- 2010-10-27 ES ES21169615T patent/ES2997997T3/es active Active
- 2010-10-27 DK DK16157716.8T patent/DK3056485T3/en active
- 2010-10-27 PT PT107819187T patent/PT2493858E/pt unknown
- 2010-10-27 HR HRP20241681TT patent/HRP20241681T1/hr unknown
- 2010-10-27 MY MYPI2012001441A patent/MY159924A/en unknown
- 2010-10-27 CN CN201080048340.1A patent/CN102596910B/zh active Active
- 2010-10-27 MX MX2012004867A patent/MX2012004867A/es active IP Right Grant
- 2010-10-27 BR BR112012008823A patent/BR112012008823B8/pt active IP Right Grant
- 2010-10-27 DK DK18163765.3T patent/DK3369732T3/da active
- 2010-10-27 HU HUE21169615A patent/HUE069657T2/hu unknown
- 2010-10-27 US US13/504,511 patent/US8975254B2/en active Active
- 2010-10-27 NZ NZ598747A patent/NZ598747A/xx unknown
- 2010-10-27 ES ES18163765T patent/ES2877248T3/es active Active
- 2010-10-27 RS RS20140420A patent/RS53469B/sr unknown
- 2010-10-27 CA CA2777896A patent/CA2777896C/en active Active
- 2010-10-27 PT PT181637653T patent/PT3369732T/pt unknown
- 2010-10-27 SI SI201032078T patent/SI3369732T1/sl unknown
- 2010-10-27 HR HRP20140919AT patent/HRP20140919T1/hr unknown
- 2010-10-27 SI SI201032153T patent/SI3885340T1/sl unknown
- 2010-10-27 PL PL16157716T patent/PL3056485T3/pl unknown
- 2010-10-27 ES ES16157716.8T patent/ES2678073T3/es active Active
- 2010-10-27 CN CN201510501603.4A patent/CN105061313B/zh active Active
- 2010-10-27 EP EP16157716.8A patent/EP3056485B1/en active Active
- 2010-10-27 SM SM20240534T patent/SMT202400534T1/it unknown
- 2010-10-27 PT PT161577168T patent/PT3056485T/pt unknown
- 2010-10-27 RS RS20241370A patent/RS66289B1/sr unknown
- 2010-10-27 UA UAA201206302A patent/UA109535C2/ru unknown
- 2010-10-27 EP EP14162075.7A patent/EP2754656A1/en not_active Withdrawn
- 2010-10-27 PH PH1/2012/500782A patent/PH12012500782A1/en unknown
- 2010-10-27 LT LTEP21169615.8T patent/LT3885340T/lt unknown
- 2010-10-27 LT LTEP16157716.8T patent/LT3056485T/lt unknown
- 2010-10-27 HU HUE16157716A patent/HUE039390T2/hu unknown
2012
- 2012-03-12 IL IL218586A patent/IL218586A/en active IP Right Grant
- 2012-03-28 CL CL2012000772A patent/CL2012000772A1/es unknown
- 2012-04-12 ZA ZA2012/02655A patent/ZA201202655B/en unknown
- 2012-04-27 CO CO12069611A patent/CO6531494A2/es active IP Right Grant
2014
- 2014-09-23 SM SM201400138T patent/SMT201400138B/xx unknown
2015
- 2015-01-16 US US14/598,973 patent/US9657003B2/en active Active
- 2015-03-30 IL IL238044A patent/IL238044A/en active IP Right Grant
2017
- 2017-04-13 US US15/486,995 patent/US10118933B2/en active Active
2018
- 2018-07-31 HR HRP20181229TT patent/HRP20181229T1/hr unknown
- 2018-09-25 US US16/140,716 patent/US10711013B2/en active Active
2020
- 2020-02-24 US US16/799,270 patent/US11046713B2/en active Active
- 2020-05-11 NL NL301041C patent/NL301041I2/nl unknown
- 2020-05-19 LU LU00154C patent/LUC00154I2/fr unknown
- 2020-05-26 HU HUS2000012C patent/HUS2000012I1/hu unknown
- 2020-06-05 CY CY2020010C patent/CY2020010I2/el unknown
- 2020-06-17 NO NO2020018C patent/NO2020018I1/no unknown
- 2020-06-26 LT LTPA2020514C patent/LTC2493858I2/lt unknown
2021
- 2021-07-22 HR HRP20211180TT patent/HRP20211180T1/hr unknown
- 2021-08-10 CY CY20211100717T patent/CY1124429T1/el unknown

Also Published As

Publication number	Publication date
SMT202400534T1 (it)	2025-01-14
PL3369732T3 (pl)	2021-12-06
RS53469B (sr)	2014-12-31
NZ598747A (en)	2013-06-28
CA2777896A1 (en)	2011-05-05
AU2010311299A1 (en)	2012-04-12
EP2493858B1 (en)	2014-07-02
EP3369732B1 (en)	2021-05-26
GEP20166472B (en)	2016-05-10
US11046713B2 (en)	2021-06-29
DK3056485T3 (en)	2018-07-30
PT2493858E (pt)	2014-09-03
NO2020018I1 (no)	2020-06-17
AR078793A1 (es)	2011-12-07
BR112012008823B8 (pt)	2021-05-25
LT3056485T (lt)	2018-07-25
MX2012004867A (es)	2012-06-08
IL238044A (en)	2016-07-31
FI3885340T3 (fi)	2025-02-03
CY2020010I1 (el)	2020-11-25
ES2997997T3 (en)	2025-02-18
LTC2493858I2 (lt)	2022-03-25
CN102596910B (zh)	2015-11-25
HUE039390T2 (hu)	2018-12-28
LUC00154I2 (pt)	2021-02-17
SMT201400138B (it)	2014-11-10
UA109535C2 (uk)	2015-09-10
PL2493858T3 (pl)	2015-01-30
JP2013508447A (ja)	2013-03-07
DK3369732T3 (da)	2021-07-26
HRP20181229T1 (hr)	2018-10-05
SI3885340T1 (sl)	2025-02-28
ES2486263T3 (es)	2014-08-18
EP3056485B1 (en)	2018-05-09
PL3885340T3 (pl)	2025-03-24
EP3885340B1 (en)	2024-11-27
AU2010311299A8 (en)	2012-06-14
CN102596910A (zh)	2012-07-18
PH12012500782A1 (en)	2016-05-27
CY2020010I2 (el)	2020-11-25
SI3056485T1 (en)	2018-08-31
SI2493858T1 (sl)	2014-10-30
US10118933B2 (en)	2018-11-06
LTPA2020514I1 (lt)	2020-07-27
AU2010311299B2 (en)	2014-07-17
PT3885340T (pt)	2024-12-16
PT3056485T (pt)	2018-07-31
KR101654529B1 (ko)	2016-09-06
SI3369732T1 (sl)	2021-08-31
CA2777896C (en)	2017-05-23
CL2012000772A1 (es)	2012-08-24
RS57592B1 (sr)	2018-11-30
CO6531494A2 (es)	2012-09-28
BR112012008823B1 (pt)	2021-01-12
IL218586A (en)	2015-10-29
US9657003B2 (en)	2017-05-23
AU2010311299C1 (en)	2023-02-02
EP2754656A1 (en)	2014-07-16
HK1173442A1 (zh)	2013-05-16
WO2011051540A8 (en)	2012-05-24
ES2877248T3 (es)	2021-11-16
KR20120102057A (ko)	2012-09-17
SMT202100480T1 (it)	2021-09-14
US10711013B2 (en)	2020-07-14
HRP20140919T1 (hr)	2014-11-21
CN105061313A (zh)	2015-11-18
PE20121058A1 (es)	2012-08-18
KR101670299B1 (ko)	2016-10-28
EA201270597A1 (ru)	2012-10-30
EP2493858A1 (en)	2012-09-05
HRP20241681T1 (hr)	2025-02-28
CY1124429T1 (el)	2022-07-22
WO2011051540A1 (en)	2011-05-05
CN105061313B (zh)	2017-07-18
LUC00154I1 (pt)	2020-05-19
RS62123B1 (sr)	2021-08-31
EP3369732A1 (en)	2018-09-05
LT3885340T (lt)	2024-12-27
US20190100536A1 (en)	2019-04-04
MY159924A (en)	2017-02-15
HUE055528T2 (hu)	2021-12-28
ES2678073T3 (es)	2018-08-08
HUS2000012I1 (hu)	2020-07-28
HUE069657T2 (hu)	2025-04-28
NL301041I2 (nl)	2020-09-14
WO2011051540A9 (en)	2012-06-21
EP3056485A1 (en)	2016-08-17
PL3056485T3 (pl)	2018-12-31
US20200299307A1 (en)	2020-09-24
DK3885340T3 (da)	2025-01-06
HRP20211180T1 (hr)	2021-10-15
DK2493858T3 (da)	2014-09-08
BR112012008823A2 (pt)	2019-02-19
JP5763083B2 (ja)	2015-08-12
US8975254B2 (en)	2015-03-10
US20170260206A1 (en)	2017-09-14
EP3885340A1 (en)	2021-09-29
RS66289B1 (sr)	2025-01-31
ZA201202655B (en)	2012-12-27
LT3369732T (lt)	2021-06-25
US20150203479A1 (en)	2015-07-23
EA021170B1 (ru)	2015-04-30
US20120225867A1 (en)	2012-09-06
KR20160105927A (ko)	2016-09-07
IL218586A0 (en)	2012-05-31

Publication	Publication Date	Title
HUS2000012I1 (hu)	2020-07-28	Androgén-receptor-moduláló vegyületek
IL215267A0 (en)	2011-11-30	Substituted spiro-amide compounds
SI2297100T1 (sl)	2013-02-28	Tetrahidrociklopenta(b)indoli kot modulatorji androgenskega receptorja
GB0907425D0 (en)	2009-06-10	Compounds
EP2393493A4 (en)	2013-07-17	LINKS
GB0907515D0 (en)	2009-06-10	Compounds
ZA201101707B (en)	2012-01-25	Novel imidazolidine compounds as androgen receptor modulators
GB201004739D0 (en)	2010-05-05	Receptor modulators
ZA201205726B (en)	2013-09-25	Substituted naphthalenyl-pyrimidine compounds
GB0905641D0 (en)	2009-05-13	Compounds
EP2443115A4 (en)	2012-10-24	COMPOUNDS
GB0906433D0 (en)	2009-05-20	Compounds
GB0904746D0 (en)	2009-05-06	Compounds
GB0903492D0 (en)	2009-04-08	Compounds
GB0902259D0 (en)	2009-03-25	Compounds
GB0906378D0 (en)	2009-05-20	Compounds
GB0905062D0 (en)	2009-05-06	Compounds
GB0905060D0 (en)	2009-05-06	Compounds
GB0905057D0 (en)	2009-05-06	Compounds
GB0902156D0 (en)	2009-03-25	Compounds
GB0904729D0 (en)	2009-05-06	Compounds
GB0900456D0 (en)	2009-02-11	Compounds
GB0903948D0 (en)	2009-04-22	Compounds
GB0906854D0 (en)	2009-06-03	Compounds
GB0906853D0 (en)	2009-06-03	Compounds